Press Releases
- Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS April 24, 2019 13:00 (CEST)Regulatory
- Active Biotech completes sale of property April 5, 2019 14:15 (CEST)Regulatory
- Extraordinary General Meeting of Active Biotech AB April 4, 2019 18:00 (CEST)Regulatory
- NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL) March 13, 2019 18:15 (CET)Regulatory
- Active Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on April 4, 2019 March 13, 2019 18:00 (CET)Regulatory
- Active Biotech Year-end report January - December 2018 February 14, 2019 08:30 (CET)Regulatory
- Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI® (durvalumab) in the upcoming Phase 1b/2 study February 11, 2019 14:00 (CET)Regulatory
- Active Biotech has received an indicative bid for the property in Lund - the Board is positive February 1, 2019 16:15 (CET)Regulatory
- Active Biotech provides updated information about the company's financial position December 10, 2018 12:30 (CET)Regulatory
- Active Biotech's election committee appointed November 19, 2018 08:30 (CET)